Adhera Therapeutics, Inc.
ATRX
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.40K | 58.00K | 69.00K | 32.00K | 133.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.70K | 24.00K | 35.00K | 47.00K | 123.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 44.10K | 82.00K | 104.00K | 79.00K | 256.00K |
|
|
|||||
| Total Current Assets | 44.10K | 82.00K | 104.00K | 79.00K | 256.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 44.10K | 82.00K | 104.00K | 79.00K | 256.00K |
|
|
|||||
| Total Accounts Payable | 2.35M | 2.32M | 2.41M | 2.40M | 2.31M |
| Total Accrued Expenses | 5.61M | 5.16M | 4.75M | 4.40M | 4.05M |
| Short-term Debt | 10.83M | 10.59M | 9.63M | 8.59M | 7.99M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 7.57M | 4.81M | 6.42M | 6.88M | 7.71M |
| Total Other Current Liabilities | 7.57M | 4.81M | 6.42M | 6.88M | 7.71M |
| Total Current Liabilities | 26.36M | 22.87M | 23.20M | 22.27M | 22.06M |
|
|
|||||
| Total Current Liabilities | 26.36M | 22.87M | 23.20M | 22.27M | 22.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 10.83M | 10.59M | 9.63M | 8.59M | 7.99M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.36M | 22.87M | 23.20M | 22.27M | 22.06M |
|
|
|||||
| Common Stock & APIC | 33.67M | 33.63M | 33.57M | 33.57M | 33.57M |
| Retained Earnings | -59.98M | -56.42M | -56.66M | -55.75M | -55.37M |
| Treasury Stock & Other | -2.00K | -2.00K | -2.00K | -2.00K | -2.00K |
| Total Common Equity | -26.32M | -22.79M | -23.09M | -22.19M | -21.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.32M | -22.79M | -23.09M | -22.19M | -21.81M |
| Total Preferred Equity | 0.00 | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.32M | -22.79M | -23.09M | -22.19M | -21.81M |
|
|
|||||
